CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signalingSamantha M. Fix, Amir A. Jazaeri, Ana Lucía Dominguez et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 44